Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease

The use of therapeutic drug monitoring has been proposed as a useful tool in the management of patients with loss of response to biological therapy in patients with inflammatory bowel disease.

Source: Digestive and Liver Disease - November 27, 2017 Category: Gastroenterology Authors: Giorgia Bodini, Edoardo G. Giannini, Vincenzo Savarino, Lorenzo Del Nero, Sara Lo Pumo, Matteo Brunacci, Nicola De Bortoli, Anjali Jain, Salvatore Tolone, Edoardo Savarino Tags: Alimentary Tract Source Type: research